M&A Deal Summary |
|
---|---|
Date | 2022-02-28 |
Target | IntriCon |
Sector | Medical Products |
Buyer(s) | Altaris Capital Partners |
Deal Type | Going Private |
Deal Value | 241M USD |
Advisor(s) | Piper Sandler & Co. (Financial) Blank Rome (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2003 |
PE ASSETS | 5.0B USD |
Size | Large |
Type | Sector Focused |
Altaris Capital Partners is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris Capital Partners was formed in 2004 and is based in New York City.
DEAL STATS | # |
---|---|
Overall | 34 of 34 |
Sector (Medical Products) | 13 of 13 |
Type (Going Private) | 2 of 2 |
State (Minnesota) | 4 of 4 |
Country (United States) | 32 of 32 |
Year (2022) | 1 of 1 |
Size (of disclosed) | 5 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-17 |
Veranova
Wayne, Pennsylvania, United States Veranova is a developer and manufacturer of specialist and complex active pharmaceutical ingredients for pharma and biotech companies. Veranova was founded in 1970 and is based in Wayne, Pennsylvania. |
Buy | £325M |